2/18
03:15 pm
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/18
10:20 am
atrc
Rating for ATRC
Low
Report
Rating for ATRC
2/18
08:13 am
atrc
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
Medium
Report
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $54.00 price target on the stock.
2/18
07:01 am
atrc
AtriCure (NASDAQ:ATRC) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Medium
Report
AtriCure (NASDAQ:ATRC) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
2/18
07:01 am
atrc
AtriCure (NASDAQ:ATRC) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.
Medium
Report
AtriCure (NASDAQ:ATRC) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.
2/18
06:38 am
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/18
06:38 am
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/18
06:09 am
atrc
AtriCure downgraded to Perform from Outperform at Oppenheimer
Medium
Report
AtriCure downgraded to Perform from Outperform at Oppenheimer
2/18
06:09 am
atrc
AtriCure downgraded to Perform from Outperform at Oppenheimer
Medium
Report
AtriCure downgraded to Perform from Outperform at Oppenheimer
2/18
05:19 am
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/12
08:04 am
atrc
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
Low
Report
AtriCure (NASDAQ:ATRC) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $45.00 price target on the stock.
2/12
06:16 am
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/12
06:16 am
atrc
Rating for ATRC
Medium
Report
Rating for ATRC
2/11
08:00 am
atrc
AtriCure (NASDAQ:ATRC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock.
Medium
Report
AtriCure (NASDAQ:ATRC) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $36.00 price target on the stock.
2/11
05:11 am
atrc
AtriCure downgraded to Neutral from Overweight at JPMorgan
Medium
Report
AtriCure downgraded to Neutral from Overweight at JPMorgan
12/16
10:35 am
atrc
Rating for ATRC
Low
Report
Rating for ATRC